|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$21.77 |
$22.20 |
$20.88 |
$21.83 |
1.02M | 04/23/2024 |
$21.78 |
$22.85 |
$21.50 |
$21.53 |
849.50K | 04/24/2024 |
$21.56 |
$21.73 |
$21.03 |
$21.17 |
859.30K | 04/25/2024 |
$20.53 |
$20.66 |
$19.64 |
$20.02 |
1.46M | 04/26/2024 |
$20.11 |
$20.98 |
$19.37 |
$20.76 |
1.02M |
|
Intellia Therapeutics is a genome editing company focused on developing therapeutics using CRISPR/Cas9 technology. CRISPR/Cas9, an acronym for Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9), is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid (DNA). To realize the transformative potential of CRISPR/Cas9-based technologies, Co. is building a range of genome editing company, by utilizing its modular platform, to advance in vivo and ex vivo therapies for diseases with high unmet need. | |
|
Intellia Therapeutics (NTLA) has the following price history information. Looking back at NTLA historical stock prices for the last five trading days, on April 22, 2024, NTLA opened at $21.77, traded as high as $22.20 and as low as $20.88, and closed at $21.83. Trading volume was a total of 1.02M shares. On April 23, 2024, NTLA opened at $21.78, traded as high as $22.85 and as low as $21.50, and closed at $21.53. Trading volume was a total of 849.50K shares. On April 24, 2024, NTLA opened at $21.56, traded as high as $21.73 and as low as $21.03, and closed at $21.17. Trading volume was a total of 859.30K shares. On April 25, 2024, NTLA opened at $20.53, traded as high as $20.66 and as low as $19.64, and closed at $20.02. Trading volume was a total of 1.46M shares. On April 26, 2024, NTLA opened at $20.11, traded as high as $20.98 and as low as $19.37, and closed at $20.76. Trading volume was a total of 1.02M shares.
NTLA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Intellia Therapeutics shares, starting with a $10,000 purchase of NTLA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/09/2016 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$24.00 |
|
End price/share: |
$20.76 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-13.50% |
|
Average Annual Total Return: |
-1.80% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,652.26 |
|
Years: |
7.97 |
|
|
|
Date |
Close |
04/22/2024 | $21.83 | 04/23/2024 | $21.53 | 04/24/2024 | $21.17 | 04/25/2024 | $20.02 | 04/26/2024 | $20.76 |
|
|